Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment

Neurology

Volumn 74, Issue 11, 2010, Pages 934-

  Killestein, J ^a   Van Der Meer, M L ^a   Regelink, J C ^a   Huijgens, P C ^a   Polman, C H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOXANTRONE; ANTINEOPLASTIC AGENT;

ADULT; BONE MARROW SUPPRESSION; CARDIOTOXICITY; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FATIGUE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEG EDEMA; LETTER; LEUKEMIA; LOW DRUG DOSE; MULTIPLE SCLEROSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; NOTE; TIME;

ANTINEOPLASTIC AGENTS; FEMALE; HEART FAILURE; HUMANS; MIDDLE AGED; MITOXANTRONE; MULTIPLE SCLEROSIS; TIME FACTORS;

EID: 77950480232     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d2b7de     Document Type: Letter

References (3)

1. J Dörr A Bitsch KJ Schmailzl Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment Neurology 73 2009 991 993
2. S Goffette V van Pesch JL Vanoverschelde E Morandini CJ Sindic Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone J Neurol 252 2005 1217 1222
3. FDA MedWatch Safety Alert Mitoxantrone hydrochloride (marketed as Novantrone and generics) Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm092708.htm July 29, 2008 Accessed October 15, 2009.